Pamela Thomas-Graham
CIK 1327431 · last filed 2026-06-11
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$5.73M
Companies
7
Total Filings
97
Lifetime Open-Market Net
-$28.94M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| PTON | Director | 134,776 | $5.50 | $741.9K | -$29.20M | 29 | 2026-06-11 |
| BMBL | Director | 164,663 | $2.85 | $468.5K | $498.2K | 5 | 2026-06-05 |
| COMP | Director | 186,588 | $12.58 | $2.35M | -$374.3K | 11 | 2026-05-15 |
| RIVN | Director | 56,279 | $15.38 | $865.6K | $1.00M | 14 | 2024-06-21 |
| CLX | Director | 9,778 | $105.60 | $1.03M | -$863.2K | 28 | 2021-01-05 |
| NCLH | Director | 14,318 | $19.37 | $277.3K | $0 | 4 | 2021-01-05 |
| IDENIX PHARMACEUTICALS INC (IDIX) Delisted | Director | — | — | — | $0 | 3 | 2009-06-03 |
Recent Filings · Page 2 of 10
97 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-05-27 | COMP | Grant (A) | — | $0 | EDGAR |
| 2025-03-05 | PTON | Exer (M) | +6,349 | $0 | EDGAR |
| 2025-02-21 | COMP | Mixed | −8,811 | -$148.1K | EDGAR |
| 2025-02-19 | COMP | Notice (144) | −35,683 | -$284.8K | EDGAR |
| 2025-01-21 | PTON | Mixed | +201 | $0 | EDGAR |
| 2024-12-05 | PTON | Mixed | +14,912 | $0 | EDGAR |
| 2024-11-22 | PTON | Mixed | — | -$239.7K | EDGAR |
| 2024-11-21 | PTON | Notice (144) | −26,630 | -$222.6K | EDGAR |
| 2024-09-16 | COMP | Sell (S) | −8,811 | -$53.1K | EDGAR |
| 2024-09-12 | COMP | Notice (144) | −8,811 | -$52.8K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.